Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is an antiviral that works by stopping coronavirus from growing and spreading. Merck & Co Inc via Reuters
Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is an antiviral that works by stopping coronavirus from growing and spreading. Merck & Co Inc via Reuters

WHO recommends molnupiravir for Covid patients who may need hospital treatment